RE:RE:RE:RE:RE:RE:RE:Great interview!Waxie, while you make great points for the rights plan, my view is a rights plan is a mote point because no investor is going to buy Sirona based on some pie in the sky hopes that the science somehow becomes valuable. Prove the science and the shareprice will respond accordingly.
Right now, I think the shareholders rights plan is there to protect a weak management team that can't seem to get things going. As a matter of fact, I would welcome a buy out right now as I think a new team will return value by doing whatever is needed to drive the science and prove it up. The buyers must feel they can do a better job than those at the wheel right now. ...even at 29 cents is a good deal for shareholders IMHO.